iRhythm Technologies, Inc. (IRTC) stock surged +1.91%, trading at $110.79 on NASDAQ, up from the previous close of $108.71. The stock opened at $107.64, fluctuating between $106.41 and $111.50 in the recent session.
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Employees | 2000 |
Beta | 1.23 |
Sales or Revenue | $492.68M |
5Y Sales Change% | 1.617% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
iRhythm Technologies, Inc. (NASDAQ: IRTC) stock price is $110.79 in the last trading session. During the trading session, IRTC stock reached the peak price of $111.50 while $106.41 was the lowest point it dropped to. The percentage change in IRTC stock occurred in the recent session was 1.91% while the dollar amount for the price change in IRTC stock was $2.08.
The NASDAQ listed IRTC is part of Medical - Devices industry that operates in the broader Healthcare sector. iRhythm Technologies, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Brice Bobzien C.P.A.
Chief Financial Officer
Mr. Patrick Michael Murphy J.D.
Chief Bus. & Legal Officer
Mr. Douglas J. Devine
Executive Advisor
Mr. Mazi Kiani
Senior Vice President of Quality & Regulatory
Mr. Mark J. Day Ph.D.
Chief Technology Officer
Mr. Quentin S. Blackford
Pres, Chief Executive Officer & Director
Mr. Brice Bobzien CPA
Chief Financial Officer
Ms. Sumi Shrishrimal
Executive Vice President & Chief Risk Officer
Mr. Chad M. Patterson
Chief Commercial Officer
Dr. Minang P. Turakhia M.D., M.S.
Chief Medical & Scientific Officer and Executive Vice President of Product Innovation
Mr. David A. Vort
Strategic Advisor
Mr. Daniel G. Wilson
Executive Vice President of Corporation Strategy
Dr. Mintu P. Turakhia M.D.
Chief Medical Officer & Chief Scientific Officer
Dr. Mintu P. Turakhia M.D., M.S.
Chief Medical & Scientific Officer and Executive Vice President of Product Innovation
Ms. Reyna M. Fernandez
Chief HR Officer
Stephanie Zhadkevich
Director of Investor Relations
IRTC's closing price is 98.12% higher than its 52-week low of $55.92 where as its distance from 52-week high of $124.12 is -10.74%.
Number of IRTC employees currently stands at 2,000.
Official Website of IRTC is: https://www.irhythmtech.com
IRTC could be contacted at phone 415 632 5700 and can also be accessed through its website. IRTC operates from 699 8th Street, San Francisco, CA 94103, United States.
IRTC stock volume for the day was 438.81K shares. The average number of IRTC shares traded daily for last 3 months was 451.49K.
The market value of IRTC currently stands at $3.47B with its latest stock price at $110.79 and 31.3M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com